University of Edinburgh
Feasibility of a mobile health app to improve nasal corticosteroid adherence in allergic rhinitis and asthma
Abstract
dc:description.abstractBACKGROUND: Allergic rhinitis (AR) is one of the most common diseases globally, estimated to affect over 400 million people, and typically persists throughout life. Poorly controlled AR can reduce quality of life, lead to substantial direct and indirect costs associated with medical expenses and reduction in work and school performance and may trigger asthma symptoms and asthma exacerbations in people with both AR and asthma. Nasal corticosteroids (NCS) are widely recognised as the most effective medication class for controlling AR, however, NCS adherence remains largely poor and inconsistent for many. Mobile health (mHealth) interventions could be a potential tool to improve NCS adherence through the use of features that principally promote patient communication, empowerment, monitoring and education. However, user engagement with mHealth interventions remains a major obstacle as it can significantly hamper the ability to improve NCS adherence and better control AR and asthma. AIMS AND OBJECTIVES: Following the combination of the MRC framework for developing complex interventions and the IDEAS framework, the aim was to: •Aim 1: Explore the evidence base •Aim 2: Integrate insights from users and theory •Aim 3: Develop an mHealth app •Aim 4: Explore the feasibility of an mHealth app for improving NCS adherence METHODS AND RESULTS: Aim 1: A systematic review exploring the effectiveness of mHealth interventions for improving NCS adherence in AR was conducted. Overall, findings indicated an immature evidence base. The few included studies did show signals that mHealth interventions could improve NCS adherence, while effects on longer-term outcomes remained unclear. Little information was available on mHealth usability/acceptability or engagement. Aim 2: Insights from two patient and public involvement (PPI) advisory groups on experiences living with AR and asthma and adhering to NCS were explored. Using these insights, appropriate theory underpinning the mHealth app was identified. Aim 3: An app review was used to uncover popular features and user experiences of commercial mHealth apps for improving AR medication adherence and self-management. Based on findings from aims 1, 2 and 3, an mHealth app was subsequently developed using a user-centred approach involving PPI input. Aim 4: The feasibility of the mHealth app was assessed through conducting a 6-week feasibility study. Participants were recruited through seven GP practices from NHS Lothian and NHS Kent and Medway. The study was also advertised through social media accounts of the Asthma UK Centre for Applied Research (AUKCAR) and in email newsletters sent from Asthma + Lung UK and through relevant University of Edinburgh (UoE) student unions. A questionnaire, interviews and mHealth app engagement data were used to assess: 1) usability, acceptability, and engagement with the mHealth intervention, 2) feasibility of study recruitment, and 3) feasibility of study outcomes. Seven young people (16-29 years) with AR and asthma used the app. Participants reported high usability and acceptability of the mHealth app, while the study demonstrated good feasibility of study outcomes. However, the study also identified issues with the feasibility of study recruitment, retention and engagement with the app. Pre-determined stop-go progression criteria were initially embedded to make judgements about the intervention’s suitability to be assessed in a future definitive trial but were infeasible due to the very small sample size. CONCLUSIONS: MHealth apps might offer a feasible option to improve NCS adherence in AR and asthma. Using a user-centred design approach and underpinning its content and features in behaviour change theory might be instrumental in providing more useful and acceptable mHealth apps. However, recruitment methods, app content, and implementation should be carefully considered prior to conducting future research.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Baxter, Mats Stage
- Advisors dc:contributor.advisor
-
- Schwarze, Jurgen
- Sheikh, Aziz
- Bush, Andrew
Subjects
dc:subject × 8Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.7488/era/7363